Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary
This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention
of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report …
of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report …
[HTML][HTML] Kinetics of viral load and antibody response in relation to COVID-19 severity
…, Z Chen, Z Zhuang, J Zhuo, C Chen… - The Journal of …, 2020 - Am Soc Clin Investig
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent for
coronavirus 2019 (COVID-19) pneumonia. Little is known about the kinetics, tissue distribution…
coronavirus 2019 (COVID-19) pneumonia. Little is known about the kinetics, tissue distribution…
Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma
…, TB Casale, M Chan-Yeung, R Chen… - Journal of Allergy and …, 2010 - Elsevier
Asthma is a global health problem affecting around 300 million individuals of all ages, ethnic
groups and countries. It is estimated that around 250,000 people die prematurely each year …
groups and countries. It is estimated that around 250,000 people die prematurely each year …
[PDF][PDF] Generation of a broadly useful model for COVID-19 pathogenesis, vaccination, and treatment
…, R Chen, AN Alshukairi, Z Chen, Z Zhang, C Chen… - Cell, 2020 - cell.com
COVID-19, caused by SARS-CoV-2, is a virulent pneumonia, with >4,000,000 confirmed
cases worldwide and >290,000 deaths as of May 15, 2020. It is critical that vaccines and …
cases worldwide and >290,000 deaths as of May 15, 2020. It is critical that vaccines and …
Inhalation delivery of dexamethasone with iSEND nanoparticles attenuates the COVID-19 cytokine storm in mice and nonhuman primates
Dexamethasone (DEX) is the first drug to show life-saving efficacy in patients with severe
coronavirus disease 2019 (COVID-19), while DEX is associated with serious adverse effects. …
coronavirus disease 2019 (COVID-19), while DEX is associated with serious adverse effects. …
Multi-omics analyses of airway host–microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventions
Z Yan, B Chen, Y Yang, X Yi, M Wei… - Nature …, 2022 - nature.com
The mechanistic role of the airway microbiome in chronic obstructive pulmonary disease (COPD)
remains largely unexplored. We present a landscape of airway microbe–host …
remains largely unexplored. We present a landscape of airway microbe–host …
[HTML][HTML] Chinese experts' consensus on the Internet of Things-aided diagnosis and treatment of coronavirus disease 2019 (COVID-19)
…, L Tong, X Zhu, N Zhong, C Bai, CA Powell, R Chen… - Clinical eHealth, 2020 - Elsevier
The aim is to diagnose COVID-19 earlier and to improve its treatment by applying medical
technology, the “COVID-19 Intelligent Diagnosis and Treatment Assistant Program (nCapp)” …
technology, the “COVID-19 Intelligent Diagnosis and Treatment Assistant Program (nCapp)” …
Longitudinal profile of antibodies against SARS‐coronavirus in SARS patients and their clinical significance
…, X Ren, H Li, C Ke, Y Tan, C Cai, K Lai, R Chen… - …, 2006 - Wiley Online Library
Background: Severe acute respiratory syndrome (SARS) is a newly discovered disease
caused by a novel coronavirus. The present study studied the longitudinal profile of antibodies …
caused by a novel coronavirus. The present study studied the longitudinal profile of antibodies …
[HTML][HTML] Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated international task force …
…, M Belliato, HA Chami, R Chen… - European …, 2020 - Eur Respiratory Soc
Background Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute
respiratory syndrome-coronavirus-2. Consensus suggestions can standardise care, thereby …
respiratory syndrome-coronavirus-2. Consensus suggestions can standardise care, thereby …
[HTML][HTML] Expert consensus on the metaverse in medicine
D Yang, J Zhou, R Chen, Y Song, Z Song, X Zhang… - Clinical eHealth, 2022 - Elsevier
Background Recently, Professor Chunxue Bai and colleagues have proposed a definition of
the Metaverse in Medicine as the medical Internet of Things (MIoT) facilitated using AR and/…
the Metaverse in Medicine as the medical Internet of Things (MIoT) facilitated using AR and/…